Potential clinical applications of extracellular vesicles in pancreatic cancer: exploring untapped opportunities from biomarkers to novel therapeutic approaches
2024

Extracellular Vesicles and Pancreatic Cancer: New Opportunities

publication Evidence: moderate

Author Information

Author(s): Sanchez-Manas Jose Manuel, Perez de Gracia Natalia, Perales Sonia, Martinez-Galan Joaquina, Torres Carolina, Real Pedro J.

Primary Institution: University of Granada

Hypothesis

Can extracellular vesicles serve as effective biomarkers and therapeutic agents for pancreatic cancer?

Conclusion

Extracellular vesicles show promise as non-invasive biomarkers and therapeutic agents for pancreatic cancer.

Supporting Evidence

  • Extracellular vesicles can be found in blood, urine, and saliva, making them accessible for non-invasive testing.
  • EVs carry proteins and nucleic acids that reflect the state of the originating cells, which can be used for cancer detection.
  • Studies suggest that EVs can enhance tumor growth and resistance to chemotherapy in pancreatic cancer.

Takeaway

Scientists are studying tiny bubbles called extracellular vesicles that can help find and treat pancreatic cancer without needing painful tests.

Methodology

This review examines the roles of extracellular vesicles in pancreatic cancer and their potential as biomarkers and therapeutic targets.

Limitations

The review is based on existing literature and may not include all recent findings.

Digital Object Identifier (DOI)

10.20517/evcna.2023.68

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication